The TGA has accepted the Australian Influenza Vaccine Committee (AIVC) recommendations for the following viruses be included in egg-based quadrivalent influenza vaccines for the 2022 southern hemisphere influenza season:

  • an A/Victoria/2570/2019 (H1N1) pdm09-like virus;
  • an A/Darwin/9/2021 (H3N2) -like virus;
  • a B/Austria/1359417/2021-like (B/Victoria lineage) virus; and
  • a B/Phuket/3073/2013-like (B/Yamagata lineage) virus.

Discard all expired 2021 influenza vaccine stock in the pharmaceutical waste bin.